What this quiz covers
This quiz focuses on Signal Transduction Pathways, giving you a quick way to practice the rules, question types, and explanations that matter most for AP Biology.
In cultured liver cells, hormone H binds membrane receptor R and activates G protein Gα, which stimulates adenylyl cyclase to convert ATP to cAMP. cAMP binds protein kinase A (PKA), releasing active catalytic subunits that phosphorylate enzyme E, increasing its activity 6-fold within 30 s. A phosphodiesterase (PDE) hydrolyzes cAMP to AMP. When cells are treated with a PDE inhibitor, the same dose of H produces a larger and longer-lasting increase in E activity; however, without H the inhibitor causes little change. Which change would most likely eliminate the effect of the PDE inhibitor on E activity?
AP Biology Quiz
Practice Signal Transduction Pathways in AP Biology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.
This quiz focuses on Signal Transduction Pathways, giving you a quick way to practice the rules, question types, and explanations that matter most for AP Biology.
Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.
In cultured liver cells, hormone H binds membrane receptor R and activates G protein Gα, which stimulates adenylyl cyclase to convert ATP to cAMP. cAMP binds protein kinase A (PKA), releasing active catalytic subunits that phosphorylate enzyme E, increasing its activity 6-fold within 30 s. A phosphodiesterase (PDE) hydrolyzes cAMP to AMP. When cells are treated with a PDE inhibitor, the same dose of H produces a larger and longer-lasting increase in E activity; however, without H the inhibitor causes little change. Which change would most likely eliminate the effect of the PDE inhibitor on E activity?
Explanation: This question assesses the skill of analyzing signal transduction pathways by identifying changes that abolish the impact of a modulator on downstream enzyme activity. The pathway begins with hormone H binding receptor R to activate G protein Gα, stimulating adenylyl cyclase to produce cAMP from ATP, which activates PKA to phosphorylate and enhance enzyme E activity, while PDE hydrolyzes cAMP to limit the signal. The PDE inhibitor prolongs cAMP elevation only when H is present, leading to a larger and sustained increase in E activity, but has minimal effect without H due to low basal cAMP production. Mutating receptor R to prevent H binding blocks pathway initiation, eliminating the inhibitor's ability to enhance E activity since no cAMP is generated in response to H. A tempting distractor is choice E, which suggests overexpressing PDE to rapidly hydrolyze cAMP despite the inhibitor, but this overlooks that the inhibitor's effect depends on upstream activation, not just PDE levels, reflecting a misconception about signal dependency. A transferable strategy is to dissect how inhibitors affect pathway dynamics and test upstream blocks to confirm dependency on initial signal transduction steps.
In an experiment, cells are exposed to ligand L that activates receptor R and increases cytosolic cAMP. A FRET sensor reports PKA activity. With L alone, PKA activity peaks at 30 s and returns to baseline by 3 min. With L plus a drug that blocks receptor internalization, PKA activity remains elevated for 10 min. Ligand binding affinity is unchanged. Which explanation is best supported by these data?
Explanation: This question assesses the skill of analyzing a signal transduction pathway. Receptor internalization normally reduces signaling by removing active receptors from the membrane, so blocking it prolongs PKA activity as receptors continue activating the pathway despite unchanged binding. In the pathway, L activates R to increase cAMP and PKA, with normal transient response, but blocking internalization extends it. This supports desensitization via internalization. Choice B is tempting but wrong because it suggests internalization activates cyclase, which is a misconception as the prolonged signal indicates internalization terminates signaling. A transferable strategy is to manipulate endocytosis to study desensitization mechanisms in GPCR pathways.
In a cell-free system, activated receptor fragments phosphorylate adaptor protein Ad on tyrosines. Ad recruits enzyme PI3K, which converts membrane lipid PIP2 to PIP3. PIP3 recruits kinase Akt to the membrane, where Akt becomes phosphorylated and then phosphorylates cytosolic target X. When a lipid phosphatase that converts PIP3 back to PIP2 is added, Akt phosphorylation decreases and X phosphorylation drops. Which change would most likely counteract the effect of the lipid phosphatase?
Explanation: This question assesses the skill of analyzing signal transduction pathways by countering phosphatase effects in PI3K-Akt signaling. The lipid phosphatase converts PIP3 to PIP2, reducing PIP3, Akt membrane recruitment, phosphorylation, and X phosphorylation. Increasing PI3K activity raises PIP3 levels, opposing the phosphatase and restoring Akt activation and X phosphorylation. This boosts production to overcome degradation, maintaining the lipid signal. A tempting distractor is choice E, adding PIP2 to increase PIP3 via phosphatase, but phosphatases degrade, not produce PIP3, confusing reaction direction. For balancing enzymes, enhance the opposing activity to shift equilibrium toward the desired product.
A ligand binds receptor R and activates enzyme AC, producing cAMP. cAMP activates PKA, which phosphorylates channel Ch, increasing ion flux. A regulatory protein Reg binds PKA's catalytic subunit and reduces its activity when cAMP levels fall. In cells treated with a phosphodiesterase activator, cAMP drops quickly and channel phosphorylation decreases rapidly. Which change would most likely maintain channel phosphorylation despite rapid cAMP breakdown?
Explanation: This question assesses the skill of analyzing signal transduction pathways by selecting ways to sustain phosphorylation despite rapid cAMP breakdown. Rapid cAMP breakdown by phosphodiesterase activation causes quick loss of PKA activity and channel Ch dephosphorylation, as Reg inhibits PKA when cAMP falls. Expressing a PKA catalytic subunit active without cAMP bypasses cAMP dependence, maintaining phosphorylation even with low cAMP. This variant escapes Reg inhibition, sustaining the signal. A tempting distractor is choice B, increasing phosphodiesterase further, but this would worsen cAMP loss, not sustain it, confusing turnover with stabilization. To maintain signals, introduce components insensitive to the degrading factor.
A receptor activates a small GTPase (G) that cycles between inactive GDP-bound and active GTP-bound forms. A guanine nucleotide exchange factor (GEF) promotes GDP release so GTP can bind, activating G. A GTPase-activating protein (GAP) increases G's GTP hydrolysis, returning it to the GDP-bound form. Active G-GTP activates effector enzyme E, increasing E activity. Cells expressing a mutant G that cannot hydrolyze GTP show high E activity even without ligand stimulation. Which change would most likely restore regulation of E activity in cells expressing the mutant G?
Explanation: This question assesses the skill of analyzing a signal transduction pathway. The pathway activates GTPase G via receptor-stimulated GEF to promote GDP-GTP exchange, with GAP accelerating hydrolysis for inactivation and G-GTP activating effector E. Choice C restores regulation in mutant G cells by inhibiting E, preventing its activation despite constitutive G-GTP from impaired hydrolysis, thus controlling E activity without ligand. This counters the high basal E activity in mutants lacking GTPase function. A tempting distractor is A, overexpressing GAP, but this misconception assumes GAP can accelerate hydrolysis in a mutant that cannot hydrolyze GTP, whereas it fails to inactivate the mutant. A transferable strategy is to target downstream effectors when upstream regulators are constitutively active in signaling mutations.
A toxin covalently modifies the G subunit of a heterotrimeric G protein, preventing GTP hydrolysis but not affecting GTP binding. In cells where a GPCR normally activates adenylyl cyclase transiently, toxin-treated cells show prolonged cAMP elevation after a brief ligand pulse. Which explanation best accounts for the prolonged cAMP signal?
Explanation: This question assesses the skill of analyzing a signal transduction pathway. The toxin prevents GTP hydrolysis by the Gα subunit, which normally deactivates the G protein after activation, leading to prolonged activation of adenylyl cyclase and sustained cAMP elevation even after the ligand is removed. In the pathway, ligand binding to the GPCR causes Gα to exchange GDP for GTP and activate adenylyl cyclase, but without hydrolysis, Gα remains in the active GTP-bound state. This explains the prolonged cAMP signal as the pathway fails to terminate properly. Choice B is tempting but wrong because it assumes the toxin affects ligand dissociation from the receptor, which is a misconception about the toxin's target being the G protein rather than the receptor-ligand interaction. A transferable strategy is to map out the sequence of activation and deactivation steps in G protein-coupled pathways to identify where disruptions occur.
A signaling pathway begins when ligand X binds receptor R, activating kinase A. Kinase A phosphorylates kinase B, which phosphorylates kinase C. Kinase C phosphorylates cytosolic enzyme Y, increasing Y activity. A phosphatase PP removes phosphates from kinase C, decreasing its activity. In an experiment, cells treated with a PP inhibitor show normal kinase A activation after X addition but exhibit a larger increase in Y activity than untreated cells. Which explanation best accounts for the increased Y activity in PP-inhibited cells?
Explanation: This question assesses the skill of analyzing a signal transduction pathway. The pathway activates kinase A upon ligand X binding receptor R, leading to sequential phosphorylation of kinases B and C, which then activates enzyme Y, with phosphatase PP normally dephosphorylating C to reduce its activity. Choice A accounts for increased Y activity in PP-inhibited cells because inhibiting PP sustains kinase C phosphorylation, extending its activity and enhancing Y phosphorylation despite normal A activation. This results in a larger Y response, as seen in the experiment. A tempting distractor is C, suggesting inhibited PP decreases B phosphorylation, but this misconception confuses dephosphorylation targets, as PP acts on C to prolong, not accelerate, downstream activation. A transferable strategy is to assess how phosphatase inhibition affects phosphorylation persistence in multi-step kinase cascades.
In epithelial cells, growth factor G binds receptor tyrosine kinase R, causing autophosphorylation and recruitment of enzyme PLCγ. PLCγ generates IP3, which releases Ca2+ from the ER. Ca2+ activates protein kinase C (PKC) together with DAG at the membrane. PKC phosphorylates transporter T, increasing ion transport rate. When cells are treated with a drug that chelates cytosolic Ca2+, PKC activation and increased transport do not occur even though IP3 levels rise. Which step is directly blocked by the chelator?
Explanation: This question assesses the skill of analyzing a signal transduction pathway. The Ca²⁺ chelator directly blocks activation of PKC by preventing Ca²⁺ binding, which is required alongside DAG for PKC to phosphorylate transporter T and increase ion transport. In the pathway, G activates R autophosphorylation, PLCγ recruitment, IP₃ production, and Ca²⁺ release, but without free Ca²⁺, PKC cannot activate despite IP₃ rising. This step is disrupted downstream of IP₃ but upstream of transport. Choice C is tempting but wrong because it describes IP₃ synthesis as preventing second messenger formation, which is a misconception reversing the role of PLCγ in generating messengers. A transferable strategy is to identify cofactor requirements like Ca²⁺ in kinase activation to predict blocks in RTK pathways.
In cultured muscle cells, ligand L binds membrane receptor R and increases intracellular Ca2+. R activates G protein G\alpha, which activates adenylyl cyclase to produce cAMP. cAMP activates protein kinase A (PKA), which phosphorylates channel C, increasing Ca2+ influx. A phosphodiesterase (PDE) hydrolyzes cAMP to AMP. When cells are treated with L plus a PDE inhibitor, cAMP rises 4× higher than with L alone, and Ca2+ influx remains elevated longer. Which change would most likely reduce the duration of the Ca2+ response to L without preventing initial receptor binding?
Explanation: This question assesses the skill of analyzing a signal transduction pathway. Increasing PDE activity would accelerate cAMP breakdown, reducing the duration of PKA activation and thus shortening the Ca²⁺ influx response without affecting initial receptor binding by ligand L. In the pathway, L activates the G protein and adenylyl cyclase to produce cAMP, which activates PKA to phosphorylate channel C, but faster cAMP hydrolysis by PDE would limit this. The PDE inhibitor experiment shows that slowing cAMP breakdown prolongs the response, supporting that enhancing PDE would have the opposite effect. Choice B is tempting but wrong because mutating receptor R to prevent binding would block the initial response entirely, which is a misconception about targeting downstream steps to modulate duration without preventing initiation. A transferable strategy is to identify negative regulators like degradative enzymes in pathways and consider how altering their activity affects signal timing.
A ligand-gated receptor channel opens upon ligand binding and allows Na+ influx. The increased Na+ activates an intracellular Na+-sensitive enzyme N, which produces a second messenger M. M activates kinase K, and K phosphorylates cytosolic protein V, increasing V activity. When extracellular Na+ is replaced with an impermeant cation, ligand binding still occurs but M levels and V activity do not increase. Which step is most immediately prevented by removing extracellular Na+?
Explanation: This question assesses the skill of analyzing a signal transduction pathway. The pathway involves ligand binding opening a receptor channel for Na⁺ influx, activating enzyme N to produce messenger M, which stimulates kinase K to phosphorylate and activate protein V. Choice B is most immediately prevented by removing extracellular Na⁺, as ligand binding occurs but without Na⁺ influx, N remains inactive, blocking M production and downstream V activation. This is evidenced by unchanged M levels and V activity in the absence of Na⁺. A tempting distractor is A, ligand binding to the receptor, but this misconception assumes binding requires Na⁺, whereas the results show binding persists without influx. A transferable strategy is to pinpoint the first disrupted step in ion-dependent pathways by examining immediate downstream outputs.
Cells are stimulated with ligand L, activating a receptor that triggers a kinase cascade leading to phosphorylation of cytosolic substrate S. Adding a broad phosphatase inhibitor increases both the peak level and duration of S phosphorylation. Adding a kinase inhibitor eliminates S phosphorylation. No changes in ligand binding are detected under any condition. Which change would most likely decrease the duration of S phosphorylation without affecting its initial peak?
Explanation: This question assesses the skill of analyzing signal transduction pathways by shortening signal duration without affecting peaks in kinase cascades. Phosphatase inhibitor increases peak and duration of S phosphorylation, suggesting increasing phosphatase activity would accelerate dephosphorylation, shortening duration while leaving initial peak intact. This enhances termination without altering activation. No binding changes confirm post-activation regulation. A tempting distractor is choice C, inhibiting upstream kinase, but this eliminates the peak, not just shortens duration, confusing initiation with termination. To modulate duration, target regulators of signal decay like phosphatases.
In yeast cells, pheromone P binds a GPCR that activates a heterotrimeric G protein. The released Gβγ subunit activates a MAP kinase cascade (M1→M2→M3) through sequential phosphorylation. Activated M3 phosphorylates a cytosolic target protein X, changing its activity within minutes. A specific phosphatase removes phosphate groups from M3, decreasing M3 activity and limiting phosphorylation of X. When the phosphatase is overexpressed, pheromone P produces less phosphorylated X. Which manipulation would most likely increase phosphorylated X levels in cells overexpressing the phosphatase?
Explanation: This question tests the ability to analyze components and interventions in a signal transduction pathway. The pathway involves pheromone P activating a GPCR and MAP kinase cascade where M1 activates M2, M2 activates M3, and M3 phosphorylates X, with a phosphatase limiting M3 activity by dephosphorylation. Using an M3 variant lacking the phosphatase recognition site would reduce dephosphorylation, prolonging M3 activation and increasing phospho-X despite phosphatase overexpression. This directly protects M3 from excessive negative regulation. A tempting distractor is choice A, increasing phosphatase activity, but this misinterprets the goal by assuming more dephosphorylation helps, when it would further decrease M3 activity and phospho-X. A transferable strategy is to alter enzyme recognition sites to mitigate overactive negative regulators in phosphorylation cascades.
In pancreatic cells, ligand Z binds a GPCR that activates Gαq, stimulating PLC to generate IP3. IP3 opens ER Ca2+ channels, increasing cytosolic Ca2+. Ca2+ binds calmodulin, and the Ca2+-calmodulin complex activates kinase Cmk, which phosphorylates cytosolic enzyme V. A drug that chelates cytosolic Ca2+ is added just before Z. After Z addition, IP3 levels rise normally, but enzyme V phosphorylation is greatly reduced. Which step is most directly blocked by the Ca2+ chelator?
Explanation: This question analyzes the PLC-IP3-Ca2+ signal transduction pathway and the effect of Ca2+ chelation. The pathway flows: ligand Z → GPCR → Gαq → PLC → IP3 → ER Ca2+ release → Ca2+ binds calmodulin → Ca2+-calmodulin complex activates Cmk → Cmk phosphorylates enzyme V. The Ca2+ chelator binds free cytosolic Ca2+, preventing it from binding to calmodulin, which means the Ca2+-calmodulin complex cannot form to activate Cmk (choice C). Since IP3 levels rise normally, the chelator doesn't affect upstream steps. Students often think chelators affect Ca2+ release (choice B), but they actually sequester Ca2+ after it's already in the cytosol. When analyzing Ca2+ signaling, distinguish between Ca2+ release and Ca2+-dependent downstream events.
In cardiac cells, epinephrine binds a β-adrenergic GPCR, activating Gs and increasing cAMP. cAMP activates PKA, which phosphorylates a Ca2+ channel, increasing Ca2+ influx. Elevated Ca2+ binds a regulatory subunit of an enzyme complex, increasing the complex's catalytic activity. A second protein, arrestin, binds phosphorylated GPCRs and prevents further G protein activation without blocking epinephrine binding. Cells are treated with a kinase inhibitor that prevents GPCR phosphorylation but does not affect PKA. Which effect is most likely during continuous epinephrine exposure?
Explanation: This question analyzes how preventing receptor desensitization affects signal duration. Normally, activated GPCRs are phosphorylated by specific kinases (like GRKs), allowing arrestin to bind and block further G protein activation, thus terminating signaling. The kinase inhibitor prevents GPCR phosphorylation, so arrestin cannot bind to terminate Gs activation. This allows the epinephrine-bound receptor to continue activating Gs proteins, producing more sustained cAMP levels and prolonged PKA activity compared to normal desensitization. Choice A incorrectly suggests unphosphorylated GPCRs cannot activate G proteins, confusing the role of phosphorylation in desensitization versus initial activation. When analyzing receptor regulation, distinguish between mechanisms for initial activation (ligand binding) and subsequent inactivation (phosphorylation and arrestin binding).
A ligand L binds receptor R and activates kinase K, leading to phosphorylation of protein P. Phosphorylated P opens a chloride channel, changing membrane potential. A second protein, U, binds phosphorylated P and targets it for dephosphorylation by recruiting phosphatase D. In cells with a mutation that prevents U from binding P, channel opening persists longer after L removal. Which change would most likely reverse the persistence in the mutant cells?
Explanation: This question assesses the skill of analyzing signal transduction pathways by determining modifications that can alter signal termination in a mutant context. The normal pathway features ligand L binding receptor R to activate kinase K, which phosphorylates protein P, opening a chloride channel to change membrane potential, while protein U recruits phosphatase D to dephosphorylate P and terminate the signal. In the mutation preventing U from binding P, phosphorylated P persists, leading to prolonged channel opening after L removal because dephosphorylation is impaired. Increasing phosphatase D activity allows efficient dephosphorylation of P even without U-mediated recruitment, reversing the persistence by enabling faster signal shutoff in mutant cells. A tempting distractor is choice E, which proposes increasing U transcription to overcome the mutation by mass action, but this misunderstands that the binding defect prevents U from interacting with P regardless of quantity. A transferable strategy is to trace how mutations disrupt feedback or termination steps in pathways and evaluate changes that compensate by enhancing alternative regulatory mechanisms.
In photoreceptor cells, light activates rhodopsin (a GPCR), which activates transducin (G protein). Transducin activates phosphodiesterase (PDE), which decreases cGMP. Lower cGMP closes cGMP-gated Na+ channels, hyperpolarizing the cell. A guanylyl cyclase restores cGMP levels, reopening channels. In a mutant with reduced PDE activity, light causes a much smaller hyperpolarization. Which change would most likely increase hyperpolarization in the mutant during light exposure?
Explanation: This question assesses the skill of analyzing a signal transduction pathway. Inhibiting guanylyl cyclase would reduce cGMP synthesis, favoring channel closure and increasing hyperpolarization to compensate for reduced PDE activity in the mutant. In the visual transduction pathway, light activates rhodopsin to transducin to PDE, decreasing cGMP to close Na⁺ channels, but lower PDE means less cGMP drop and smaller hyperpolarization. Reducing cGMP production enhances the effect. Choice B is tempting but wrong because increasing cGMP would worsen the mutant's reduced response, which is a misconception about balancing synthesis and degradation. A transferable strategy is to adjust opposing enzymes like cyclases and diesterases to modulate cyclic nucleotide levels in sensory pathways.
A ligand L activates GPCR R, leading to G\alpha-GTP activation of adenylyl cyclase and increased cAMP. cAMP activates PKA, which phosphorylates enzyme X, increasing product formation. In a mutant cell line, L binding and cAMP increase are normal, but enzyme X phosphorylation is greatly reduced. Adding a membrane-permeable cAMP analog does not restore X phosphorylation. Which defect best explains the mutant phenotype?
Explanation: This question assesses the skill of analyzing a signal transduction pathway. The defect is loss of PKA catalytic activity, as normal L binding and cAMP increase occur, but X phosphorylation is reduced, and a cAMP analog fails to restore it, indicating the issue is downstream of cAMP. In the pathway, L activates R, Gα, adenylyl cyclase, and cAMP to stimulate PKA for X phosphorylation. The analog bypassing cyclase but not restoring function points to PKA itself. Choice C is tempting but wrong because inactive adenylyl cyclase would prevent cAMP increase, which is a misconception since cAMP rises normally in the mutant. A transferable strategy is to use analogs or activators to test pathway components and localize defects in second messenger systems.
In an experiment, cells are stimulated with ligand L that activates receptor R and leads to phosphorylation of protein P within 10 seconds. A kinase inhibitor blocks P phosphorylation, but a phosphatase inhibitor increases both the magnitude and duration of P phosphorylation. No changes occur in ligand binding. Which interpretation best explains the effect of the phosphatase inhibitor?
Explanation: This question assesses the skill of analyzing a signal transduction pathway. Phosphatases normally remove phosphate from P, and inhibiting them prolongs the phosphorylated state, increasing magnitude and duration as dephosphorylation is blocked while kinase activity continues. In the pathway, L activates R to phosphorylate P rapidly, and phosphatase inhibition enhances this without affecting binding. Kinase inhibitor blocking confirms phosphorylation dependence. Choice B is tempting but wrong because it reverses phosphatases' role to adding phosphate, which is a misconception of their dephosphorylating function. A transferable strategy is to use enzyme inhibitors to dissect the balance between kinases and phosphatases in regulating signal strength.
In a yeast cell, mating factor F binds GPCR R, activating G protein and a MAPK cascade: kinase M1 activates M2, which activates M3. M3 phosphorylates target protein T, changing its activity within minutes. A scaffold protein holds M1, M2, and M3 in a complex near the receptor. In cells lacking the scaffold, receptor binding and G protein activation occur, but phosphorylation of T is much lower and slower. Which mechanism best explains the scaffold effect?
Explanation: This question assesses the skill of analyzing a signal transduction pathway. The scaffold increases signaling efficiency by colocalizing M1, M2, and M3 near the receptor, promoting rapid sequential phosphorylation in the MAPK cascade despite normal receptor and G protein activation. In the yeast pathway, F activates R and G protein to the cascade, phosphorylating T, but without the scaffold, efficiency drops, leading to lower and slower T phosphorylation. This explains the scaffold's role in organization. Choice D is tempting but wrong because it suggests the scaffold transports T to the nucleus, which is a misconception as the effect is on phosphorylation rate, not localization. A transferable strategy is to consider protein complexes and scaffolds when analyzing speed and efficiency in multi-step kinase pathways.
A membrane receptor activates two parallel pathways after ligand binding. Pathway 1: G protein activates adenylyl cyclase, increasing cAMP and activating PKA, which phosphorylates substrate S1. Pathway 2: the same receptor activates PLC, producing IP3 and raising cytosolic Ca2+, activating kinase CaK, which phosphorylates substrate S2. A selective adenylyl cyclase inhibitor blocks S1 phosphorylation but does not change S2 phosphorylation. Which statement best explains the inhibitor's specificity?
Explanation: This question assesses the skill of analyzing signal transduction pathways by explaining inhibitor specificity in parallel signaling branches. The adenylyl cyclase inhibitor blocks S1 phosphorylation via pathway 1 (cAMP-PKA) but not S2 via pathway 2 (IP3-Ca2+-CaK), showing S2 depends on Ca2+ signaling independently of cAMP. This specificity arises because the pathways diverge after receptor activation, with the inhibitor targeting only the cAMP branch. The unchanged S2 confirms parallel, non-overlapping transduction. A tempting distractor is choice B, suggesting inhibition increases IP3, but there's no evidence of compensation, misunderstanding independence versus crosstalk. To dissect parallel paths, use selective inhibitors and observe which outputs are affected.